Management of cardiovascular risk in clozapine patients: how can we optimise it?

被引：0
|
作者：
Hawes, A. [1 ]
Tran, T. [1 ]
Albuloushi, A. [1 ]
Parmar, S. [2 ]
Ally, B. [2 ]
Santos, J. M. Serrano [1 ]
机构：
[1] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia
[2] Queensland Hlth, Metro South & West Moreton, Brisbane, Qld, Australia
来源：
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY | 2016年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：E40 / E40
页数：1
相关论文
共 50 条
  • [21] Can we optimise treatment of thrombosis?
    Levine, MN
    CANCER TREATMENT REVIEWS, 2003, 29 : 19 - 22
  • [22] The impact of clozapine on electrophysiological features: how can we utilize the findings?
    Price, GW
    Hills, S
    Mann, PJ
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2002, 6 (02) : 95 - 102
  • [23] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Trevor D. Hadley
    Ali M. Agha
    Christie M. Ballantyne
    Current Atherosclerosis Reports, 2021, 23
  • [24] How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Hadley, Trevor D.
    Agha, Ali M.
    Ballantyne, Christie M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (06)
  • [25] CAN WE TAKE HYPERURICEMIA AS A CARDIOVASCULAR RISK?
    Ashraf, Tariq
    Sultana, Raffat
    PAKISTAN HEART JOURNAL, 2023, 56 (01): : 1 - 2
  • [26] How can we Minimize Toxicity for our High Risk Patients?
    Nematollahi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S218 - S219
  • [27] Risk management of onco-hematological drugs: how and how fast can we improve?
    Altini, Mattia
    Bernabini, Marna
    Marchetti, Paolo
    Orlando, Laura
    Rebesco, Barbara
    Sirna, Valeria
    TUMORI JOURNAL, 2016, 102 : S15 - S29
  • [28] How can we optimise learning from trials in child and adolescent mental health?
    Axford, Nick
    Berry, Vashti
    Lloyd, Jenny
    Wyatt, Katrina
    EVIDENCE-BASED MENTAL HEALTH, 2022, 25 (03) : 93 - 95
  • [29] How can we prevent cardiovascular disease in diabetes
    Wiklund, O.
    Haversen, L.
    Pettersson, C.
    Hulten, L. M.
    JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) : 199 - 207
  • [30] CARDIOVASCULAR SCORE RISK CALCULATORS IN DIALYSIS PATIENTS: CAN WE USE THEM?
    Andronesi, Andreea Gabriella
    Stanescu, Cristina
    Burcea, Andreea-Florentina
    Andronesi, Danut
    Lupusoru, Gabriela Elena
    Lupusoru, Mircea
    Iliuta, Luminita
    Ismail, Gener
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I548 - I548
12345